PROS1 and COVID-19: Different regimens of viral-vector vaccines expressing SARC-CoV-2 S protein: Gam-COVID-Vac, Ad26.COV2.S, and ChAdOx1, were highly effective to protect against symptomatic COVID-19 (91.6%, 66.9%, and 66.7%, respectively)8–10.